Get the Stockscreener App
12.44
5.23%
0.6257
Mind Medicine Inc stock is traded at $12.44, with a volume of 892.14K.
It is up +5.23% in the last 24 hours and up +31.65% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$11.81
Open:
$12.25
24h Volume:
892.14K
Relative Volume:
0.64
Market Cap:
$945.77M
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-5.0758
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
+1.70%
1M Performance:
+31.65%
6M Performance:
+128.88%
1Y Performance:
+129.72%
1-Day Range:
$12.16
$12.75
1-Week Range:
$11.68
$12.94
52-Week Range:
$4.70
$12.94
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
12.43 | 898.60M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.80 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.35 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.78 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Needham Initiates Mind Medicine (MindMed) at Buy With $28 Price Target - MarketScreener
Mind Medicine (MNMD) Gains "Buy" Rating with New Coverage Initia - GuruFocus
Price action breakdown for Mind Medicine (MindMed) Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - newser.com
Why Mind Medicine Stock Is Skyrocketing Today - AOL.com
Is this a good reentry point in Mind Medicine (MindMed) Inc.Watch List & Trade Opportunity Analysis Reports - newser.com
Can a trend reversal in Mind Medicine (MindMed) Inc. lead to recoveryJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
Is Mind Medicine (MindMed) Inc. stock ready for a breakoutJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
What MACD and RSI say about Mind Medicine (MindMed) Inc.July 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Is Mind Medicine (MindMed) Inc. meeting your algorithmic filter criteriaJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
Relative strength of Mind Medicine (MindMed) Inc. in sector analysisMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com
Using Bollinger Bands to evaluate Mind Medicine (MindMed) Inc.Breakout Watch & Safe Swing Trade Setups - newser.com
What drives Mind Medicine MindMed Inc stock priceTake Profit Strategies & Affordable Investment Tips - earlytimes.in
Mind Medicine (MindMed) (NASDAQ:MNMD) Reaches New 12-Month HighWhat's Next? - MarketBeat
Volatility clustering patterns for Mind Medicine (MindMed) Inc.July 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Is a relief rally coming for Mind Medicine (MindMed) Inc. holdersInflation Watch & Verified Stock Trade Ideas - newser.com
Will Mind Medicine (MindMed) Inc. (MMQ) stock deliver compounding returnsBear Alert & Verified Trade Idea Suggestions - newser.com
Is Mind Medicine (MindMed) Inc. (MMQ) stock trading at attractive multiplesJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 6.8%Should You Sell? - MarketBeat
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) high institutional ownership speaks for itself as stock continues to impress, up 26% over last week - Yahoo Finance
Mind Medicine (MindMed) (NASDAQ:MNMD) Hits New 12-Month HighShould You Buy? - MarketBeat
Published on: 2025-09-29 08:42:36 - earlytimes.in
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
MEGMILK SNOW BRAND CoLtd 6MG Stock Analysis and ForecastEarnings Forecast Updates & Individual Stock Tracking Service - Early Times
Is Mind Medicine MindMed Inc a good long term investmentPrice Momentum Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Is Mind Medicine (MindMed) Inc. showing signs of accumulation2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
Mind Medicine MindMed Inc Stock Analysis and ForecastMonthly Performance Summary & Easy Tools to Analyze Your Investment Risk - earlytimes.in
MindMed (MNMD) Stock: Top Executives Sell Over $362K in Shares as Stock Nears 52-Week High - CoinCentral
Mindmed: chief legal officer Sullivan sells $110k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares By Investing.com - Investing.com Australia
MindMed (MNMD) CMO Karlin sells $75k in shares By Investing.com - Investing.com Nigeria
MindMed (MNMD) CEO Barrow sells $252,036 in shares - Investing.com India
Mindmed: chief legal officer Sullivan sells $110k in shares - Investing.com India
Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Sells $75,268.08 in Stock - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) CEO Sells $252,036.69 in Stock - MarketBeat
MindMed (MNMD) CMO Karlin sells $75k in shares - Investing.com India
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mind Medicine Inc Stock (MNMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer |
Sep 25 '25 |
Sale |
9.77 |
25,797 |
252,037 |
804,268 |
| Karlin Daniel | Chief Medical Officer |
Sep 25 '25 |
Sale |
9.77 |
7,704 |
75,268 |
430,625 |
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):